9435df69 F78d 4336 9f90 99fe4182340c 01
Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 68382-569
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 68382-569). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
9435df69 F78d 4336 9f90 99fe4182340c 02
The given text describes a medication named Acamprosate Calcium in delayed-release tablets form. It contains 333 mg of USP acamprosate calcium. The text provides information about the storage and dispensing of the tablets. The medication is manufactured by Cadia Healthcare Ltd. at Baddi, India, and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ 08534.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
